RVMD Revolution Medicines Inc reports widerthanexpected Q4 2025 per share loss as its stock dips 043 following the quarterly earnings release CACC Credit Acceptance Corporation Q4 2025 earnings miss estimates shares edge lower despite 72 percent year over year revenue growth Martin MMLP Stock Undervalued Technical Weakness 20260418 Kiniksa KNSA Q1 2026 Earnings Surprise EPS 027 Up Significant Jim Cramer on Charles Schwab The Market May Be Misjudging the Brokerage Crude Oil Futures Surge After Drone Strikes in Gulf Region Peugeot and Jeep Leverage Local EV Technology to Challenge Chinese Automakers